Ken Griffin Alcon Inc Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$88.07 - $100.79 $6.59 Million - $7.54 Million	-74,800 Reduced 85.78%	12,400 $1.24 Million
Q2 2024 Aug 14, 2024	SELL	$77.58 - $92.26 $1.05 Million - $1.25 Million	-13,500 Reduced 13.41%	87,200 $7.77 Million
Q1 2024 May 15, 2024	BUY	$74.84 - $88.15 $3.36 Million - $3.96 Million	44,900 Added 80.47%	100,700 $8.39 Million
Q4 2023 Feb 14, 2024	BUY	$69.57 - $78.12 $3.14 Million - $3.52 Million	45,100 Added 421.5%	55,800 $4.36 Million
Q3 2023 Nov 14, 2023	SELL	$76.74 - $85.2 $237,893 - $264,120	-3,100 Reduced 22.46%	10,700 $824,000
Q2 2023 Aug 14, 2023	SELL	$69.16 - $82.11 $13.5 Million - $16 Million	-195,400 Reduced 93.4%	13,800 $1.13 Million
Q1 2023 May 15, 2023	SELL	$64.46 - $77.23 $11.3 Million - $13.5 Million	-175,000 Reduced 45.55%	209,200 $14.8 Million
Q4 2022 Feb 14, 2023	BUY	$56.51 - $71.71 $14 Million - $17.7 Million	246,900 Added 179.83%	384,200 $26.3 Million
Q3 2022 Nov 14, 2022	BUY	$56.96 - $78.09 $484,160 - $663,765	8,500 Added 6.6%	137,300 $7.99 Million

729

242M

2.35M

1.65M

Ticker ALC
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 490,087,008
Market Cap $42.2B
Description
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.